Stragen Pharma’s Erythromycin withdrawn from market

…product had not met the requirements of good manufacturing practice, according to Erythromycin does not have a standard marketing authorisation in Hungary, but, at the request of certain healthcare providers, it became available through individual import licences.

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.